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A B S T R A C T
Microbial control agents (MCAs) are promising for use in sustainable agriculture. Nevertheless, they face a major
hurdle in the registration process of the European Union, one reason being unclear data requirements on me-
tabolites. This review examines the EU regulatory perspective on metabolites of MCAs for plant protection and
identifies some key issues and concerns. Current data requirements for secondary metabolites of micro-organ-
isms are based on degradation products/metabolites of chemicals. We conclude that this has contributed
strongly to the current confusion regarding how to best evaluate potential production of toxic substances by
MCAs. We suggest that data requirements should be revised and/or need guidance fit for purpose, in order to
give the EU-regulation for MCAs a stronger base in microbiological knowledge. We also suggest implementation
of a basic hazard assessment. If this is passed without any concerns, the production of unknown, potentially
toxic, substances does not need to be further investigated.
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1. Introduction
1.1. Scope
There is a growing public concern about the impact of chemical
pesticides on human health and the environment. In Europe, the
Sustainable Use of Pesticides Directive 2009/128/EC (EU, 2009a) ad-
vocates the use of integrated pest management (IPM) with preference
being given to environmentally friendly, non-chemical methods of pest
control (EU, 2009a). Biologically derived control agents have an im-
portant position among these alternative methods (Table 1). They entail
the use of macro- and micro-organisms as well as insect and plant de-
rived substances. In this review we focus on microbial control agents
(MCAs) used in plant protection, but our view is also relevant for mi-
crobial biocides and the Biocidal Product Regulation.
1.2. What is the problem?
The introduction of MCAs into the European market for practical
use in pest and disease control is a very slow and costly process. Several
authors state that Europe is lagging behind other countries when it
comes to implementation of microbial pest control in practice and that
this is primarily due to the restrictive regulatory conditions (Balog
et al., 2017; Frederiks and Wesseler, 2019; Kabaluk et al., 2010).
Table 2 illustrates that EU lags significantly behind the USA, India and
China when it comes to numbers of MCAs registered as plant protection
products. One area which has been particularly problematic and caused
delayed evaluations has been the potential production by MCAs of
secondary metabolites.
1.3. Goals of this review
In order to improve the regulatory situation for MCAs in the EU,
there is clearly a need to understand the main ambiguities of the data
requirements, and what has caused them. This review examines key
drivers and makes recommendations to develop data requirements
more fit for purpose.
In this paper, we:
• present an outline of the regulatory process of MCAs in Europe and
the evolution of legislation and data requirements for MCAs;• examine and summarise the functional roles of secondary metabo-
lites of micro-organisms in ecosystems;• identify flaws and inconsistencies in the current data requirements
for metabolites;• discuss the current risk assessment approach and suggest improve-
ments;• summarise our recommendations.
2. Evolution of data requirements from a historical perspective
In Europe, MCAs for plant protection fall under the same EU reg-
ulatory frameworks as the chemical plant protection products
(Regulation (EC) No 1107/2009 (EU, 2009b)), although there are
specific data requirements for the micro-organisms. The data require-
ments for MCAs were developed by the end of the 1990’s and published
in Commission Directive 2001/36/EC (EU, 2001). At the time of its
inception, regulatory experts did not have much experience of MCAs,
presumably because the biological control industry was still in its in-
fancy. Below we highlight key issues that we find strongly influenced
the evolution of the data requirements for microbial secondary meta-
bolites (Fig. 1).
2.1. Fear is the driver for equating secondary metabolites of MCAs with the
harmful products produced by mycotoxigenic fungi
We assume that, at the time of drafting the data requirements, there
was a concern that commercial MCAs may be developed from harmful
micro-organisms, such as mycotoxigenic fungi which are known to
produce toxic secondary metabolites. Drawing comparisons between
beneficial MCAs and harmful toxigenic micro-organisms is under-
standable since the micro-organisms may be phylogenetically related.
Consequently, data requirements are general and broad enough to ac-
commodate both current and future microbial products, including
possibly toxigenic micro-organisms. Although this may seem logical, in
Table 1
Different terms used to indicate biologically derived control agents.
Biological control agents include microorganisms, nematodes, predators and
parasitoids.
Microbial control agents (MCAs) are biological control agents consisting of
microorganisms (fungi, bacteria, viruses or protozoans).
Biological pesticides, also called biopesticides, include the microorganisms,
semiochemicals, botanicals and essential oils.
Table 2
Number of approved products worldwide1 based on representative genera of bacterial and fungal BCAs (based on Kabaluk et al., 2010). For details of the secondary
metabolites produced by these and other MCAs see OECD (2018b).
MCA genus Examples of secondary metabolites CH I USA URM EU SK CA SA NZ AU K AR
Fungi
Beauveria Beauvericin, Oosporein 12 3 2 2 2 2 3 2 0 2 2
Metarhizium Destruxins 9 1 1 0 0 1 1 0 3 0 0
Trichoderma Trichodermin 15 3 4 8 0 2 9 6 1 4 1
Lecanicillium (was Verticillium) Destruxins Bassianolide, Cyclosporin 14 1 2 3 0 1 0 1 0 0 0
All other minor species 10 18 4 8 3 7 3 2 0 4 0
Total for fungi 223 60 26 13 21 5 13 16 11 4 10 3
Bacteria
Bacillus thuringiensis 6 11 6 6 14 7 6 11 13 8 6
Bacillus Surfactin, Fengycin 0 12 6 1 12 7 5 2 1 0 2
Pseudomonas 2,3-deepoxy-2,3-didehydro-rhizoxin (DDR)2 7 4 7 3 0 2 0 0 0 0 0
Streptomyces Streptomycin, Thaxtomin A 0 2 2 1 2 2 0 0 0 0 0
All other minor species 0 2 4 2 1 2 1 3 1 0 0
Total for bacteria 2703 13 31 25 13 29 20 12 16 15 8 8
Grand total 292 73 57 38 34 34 33 28 27 19 18 11
1 China (CH), India (I), USA, Ukraine, Russia and Moldova (URM), EU, South Korea (SK), Canada (CA), South Africa (SA), New Zealand (NZ), Australia (AU),
Kenya (K), Argentina (AR).
2 EFSA (EFSA, 2017); in Pseudomonas chlororaphis.
3 Total numbers of products provided, not numbers of species or strains.
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our opinion it is a hindrance. The text of the current data requirements
is now fuelled by the evident risks posed by harmful fungi and bacteria,
with fears based foremost on some well-known mycotoxins (e.g. afla-
toxin, ochratoxin, fumonisins, trichothecenes, zearalenone) produced
by toxigenic fungi such as Aspergillus, Penicillium and Fusarium species.
The fear that MCAs could pose a serious and unpredictable risk
because of their potential ability to produce toxic metabolites remains
to date (Deising et al., 2017). However, counter arguments have been
presented (Koch et al., 2018; Lugtenberg, 2018). Secondary metabolites
of MCAs are often very different from those produced by harmful micro-
organisms even though they may involve the same biochemical path-
ways, demonstrating the genetic controls are quite different.
2.2. Precautionary principle
Regulatory experts often ask the question “can MCAs produce un-
known secondary metabolites that might be harmful to humans and
other non-target organisms?” This derives from the precautionary
principle applied in the EU, which effectively states that an MCA cannot
be approved, unless it is demonstrated to be safe. The question about
unknown secondary metabolites is understandable but it ignores the
natural roles of secondary metabolites for increasing the ecological
fitness of micro-organisms in the environment. ‘Unknown’ is equaled
with ‘unsafe’. This approach is one of the key problems in the risk as-
sessment of secondary metabolites.
2.3. Data requirements for chemicals served as the template for the data
requirements for MCAs
Risk assessment of MCAs is essential to reassure that the product
poses no unacceptable risk to the general public or the environment and
that the product is efficacious. The history of this regulatory process has
been outlined in several reviews (e.g. (Cook, 1990; Lord, 2005;
Ravensberg, 2011; Sundh and Goettel, 2013).
It is highly relevant in this perspective that under the previous
Directive 91/414/EEC for plant protection products, data requirements
were first developed for the chemical pesticides and that these formed
the template for the data requirements for MCAs. Consequently, the
data requirements for MCAs, including those about secondary meta-
bolites, were strongly influenced by risk assessment criteria for che-
micals. This was done as a matter of convenience since experience with
microbial pesticide assessments was lacking, or at least not taken into
consideration at that time.
2.4. Data requirements for MCAs are not based on current knowledge
Whereas the data requirements for chemicals were updated in the
current Commission Regulations 283/2013 and 284/2013 (EU,
2013a,b), the data requirements for micro-organisms in these regula-
tions were copied from the earlier directive of 2001. This was done in
spite of the expansion of knowledge on MCAs and the experience gained
by risk assessors and regulatory experts in the period between 2001 and
Fig. 1. Four factors (a–d) (representing sections 2.1–2.4) that influenced the text for secondary metabobolites (SMs) in the EU data requirements (DRs) for microbial
plant protection agents.
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2013 on this topic. The missed opportunity to update the data re-
quirements for MCAs and their secondary metabolites has meant that
the applicants and risk assessors still have to comply with the data re-
quirements of 2001.
Conclusion and recommendation (1)
The current data requirements for MCAs are outdated. We
conclude that they were formulated with a fear that the well-
known mycotoxins produced by toxigenic fungi are typical ex-
amples of secondary metabolites of micro-organisms.
Additionally, the data requirements for chemicals, specifically
those for their degradation and elimination products (i.e. ‘meta-
bolites’), were incorrectly copied to the data requirements con-
cerning metabolites of micro-organisms. There is clearly a need to
redraft the data requirements for secondary metabolites of MCAs
to make them more pertinent to the properties of micro-organ-
isms.
3. Knowledge on metabolites of MCAs relevant for data
requirements for risk assessment
3.1. Natural roles of secondary metabolites in ecosystems
Being micro-organisms, MCAs produce a range of secondary meta-
bolites which play a pivotal role in their development and ecology. The
secondary metabolites can have a profound impact on other organisms
(Fig. 2) and include antibiotics, pigments, toxins, effectors of ecological
competition and symbiosis, behavior-modifying chemicals (kair-
omones, pheromones), immune-modulating agents and plant growth
promoters (Bérdy, 2005; Butt et al., 2016; Demain and Sanchez, 2009;
Katz and Baltz, 2016; Netzker et al., 2015; Tyc et al., 2017). There are
many secondary metabolites which remain to be identified and whose
ecological role has not yet been established, which can perturb reg-
ulatory experts who might want to know the function of these com-
pounds. For instance, the number of known bioactive metabolites
produced by actinobacteria is over 10,000. The genus Streptomyces
approximately accounts for 70–80% of this number (Bérdy, 2005).
3.2. Do secondary metabolites of MCAs persist and accumulate?
Micro-organisms and their secreted products, whether they be pri-
mary or secondary metabolites or other types of substances, will enter
the pool of detrital organic matter which is gradually transformed and
mineralised in the degradative food webs in both terrestrial and aquatic
environments. Grazing invertebrates and protozoans play an important
role as consumers of micro-organisms and, inadvertently, their meta-
bolites in natural ecosystems (Scheepmaker and Butt, 2010). Besides
natural decay due to edaphic and climatic factors there are many stu-
dies demonstrating degradation of microbial secondary metabolites
whether they be by specific isolates or complex consortia (McDowall
et al., 2009; Rastogi et al., 2015; Sato et al., 2012; Wright et al., 2014).
Some MCAs are applied to the plant foliage and form part of the
epiphytic microbial community. These micro-organisms and their me-
tabolites are also subject to degradation due to a range of biotic and
Fig. 2. Graphical summary of the functions of microbial secondary metabolites in nature. Yellow boxes – attributes shared by both fungi and bacteria, Green box
-attributes more specific to entomopathogenic fungi (EPF), Pink boxes – attributes more specific to bacteria.1 (Humphris et al., 2002); 2 (Contreras-Cornejo et al.,
2016); 3 (Arguelles-Arias et al., 2009); 4 (Liu et al., 2017); 5 (Behie et al., 2012); 6 (Raya-Díaz et al., 2017); 7 (Chowdhury et al., 2015); 8 (Cianco et al., 2016); 9
(Bogner et al., 2017); 10 (Butt et al., 2016).
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abiotic factors, some of which overlap with those observed in the
subsurface environment, such as grazing by invertebrates and protozoa
and secondary metabolite degradation by plant associated micro-or-
ganisms (Sato et al., 2012; Wright et al., 2014). The plant canopy is a
hostile environment for most micro-organisms since it is less buffered to
climatic change compared to the soil. Fluctuations in temperature and
humidity can have a profound impact on microbial development. UV
light can oxidise and subsequently inactivate metabolites and kill the
producers of those compounds (Fargues et al., 1996; Kaiser et al.,
2019). Furthermore, rain can wash off the micro-organisms from leaf
surfaces so they end up in the soil (Inglis et al., 1995; Inyang et al.,
2000).
3.3. Quantifying secondary metabolites of MCAs
Mass production of MCAs is a highly controlled process. The re-
sulting fermentation product can be easily checked for known toxins
using chemical standards. Extraction and analytical techniques are
however only available for a few well-known metabolites. In contrast,
determining quantities of specific metabolites in the target host or en-
vironment (e.g. soil, plant) is a big challenge since the production of
these metabolites is influenced by a set of highly dynamic environ-
mental factors such as climate, microbiome, crop type etc. A rich
mixture of disparate compounds is present in these environments and it
is often difficult to trace their source. Some microbial metabolites may
be very difficult to extract and purify because they are short-lived and/
or present in small quantities. Furthermore, their production is multi-
factorial and highly dependent on scale, making it difficult to predict
when and where they should be measured. The problem is compounded
by the possible production of similar metabolites by natural populations
of microbes occupying the same niche as the applied MCA.
Data on quantities of secondary metabolites in the natural habitats
of MCAs are very scarce (Hackl et al., 2015; Mudgal et al., 2013). Of the
few compounds reported in a recent OECD report (OECD, 2018b), the
quantities of secondary metabolites were in all cases low and could only
be measured at high population densities. Furthermore, MCAs, like
other micro-organisms, do not grow exponentially in the environment,
in contrast to the situation in fermenters. Here, not only do they have
access to unlimited nutrients but are also free of the competitors and
predators of real ecosystems. To illustrate the point, the quantities of
destruxin A, B and E produced by Metarhizium species in liquid fer-
menters is at least a million-fold more than that produced in an insect
host (Fig. 3). It should be noted that these high concentrations are not
representative of concentrations present in the final product. This is
because the bulk of the secreted secondary metabolites are not har-
vested with the microbial propagule but left in the spent medium
(Skrobek et al., 2008).
Conclusion and recommendation (2)
Secondary metabolites in natural ecosystems are not easy to
quantify and consequently exposure data are usually missing. The
quantities produced in the fermenter do not reflect the range or
quantities produced in situ (on plant, in insect etc.) after appli-
cation of the plant protection product. Measuring secondary
metabolites in situ is therefore not a useful option, except perhaps
if the MCA produces a known toxin.
3.4. Metabolites of micro-organisms and degradation products of chemicals
are radically different
First of all, we need to understand what Regulation 1107/2009
means by ‘metabolite’. Point 32 of Article 3 in the regulation states:
“any metabolite or a degradation product of an active substance, safener or
synergist, formed either in organisms or in the environment”. This text could
be purposefully broad and overarching to cover both chemical and
microbial plant protection products but in reality, it fails to take into
account the difference between degradation products of chemicals and
metabolites of MCAs.
After application to crops, chemical pesticides will be broken down,
by for example enzyme degradation, UV light, or transformation by
metabolism in living organisms. Within the regulation the terms “me-
tabolite”, “breakdown product” and “degradation product” are used
interchangeably. Irrespective of the way of degradation or transfor-
mation of a chemical pesticide, the original compound will not be intact
anymore.
In contrast to degradation products/metabolites of chemical pesti-
cides, microbial secondary metabolites cannot be considered to be
breakdown products of the original micro-organism. Micro-organisms
though, produce primary metabolites (Fig. 4) which are required for the
growth and maintenance of cellular functions and include amino acids,
nucleotides, vitamins, solvents and organic acids. Secondary metabo-
lites are products of secondary metabolism and are important in eco-
logical and other activities of micro-organisms (see section ‘Natural
roles of secondary metabolites in ecosystems’) and as such are an in-
tegral part of the organism’s survival strategy in the environment.
Micro-organisms can also grow in the tissue of plants. These plant
endophytes (Fig. 4) represent many major taxonomic groups of micro-
organisms, and include genera which form actives in commercial MCA-
based products e.g. Bacillus, Pseudomonas and Beauveria (Card et al.,
2015; Liu et al., 2017; Vidal and Jaber, 2015). These endophytic micro-
organisms may exert biological control of herbivorous insects, and
confer other benefits to the plant such as improved nutrient acquisition
and tolerance to abiotic or biotic stress (Batta, 2013; Glassner et al.,
2018; Kefi et al., 2015).
When drafting the data requirements for MCAs, the term metabolite
was incorrectly copied from the chemical data requirements. This
caused the problem that microbial metabolites were more or less
treated with the same dread as degradation products/metabolites of
chemical pesticides, although their origins and functions are entirely
A B E A B E A B E
10-3
10-2
10-1
100
101
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104
105
106
 Production destruxins A, B and E
    mg/kg                   mg/L             mg/kg
culture filtrate  solid medium    larvae
 
Fig. 3. Production of destruxins A, B and E by different strains of Metarhizium
anisopliae in culture filtrate, solid medium and insect larvae. Data for culture
filtrates and solid media derive from (Amiri-Besheli et al., 2000; Chen et al.,
1999; Hsiao and Ko, 2001; Hu et al., 2006; Hutwimmer et al., 2010; Liu et al.,
2000, 2007, Loutelier et al., 1996; Moon et al., 2008; Rao et al., 2006; Seger
et al., 2006, 2004; Wahlman and Davidson, 1993; Wang et al., 2003, 2004,
2009). Data from larvae derive from (Amiri-Besheli et al., 2000; Skrobek et al.,
2008; Suzuki et al., 1971).
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different. The use of the same term ‘metabolite’ for two very different
kinds of substances significantly adds to the misunderstanding, but is
unlikely to change because the term is firmly embedded in the scientific
and risk assessment literature. Lucid, robust definitions are required
which distinguish between metabolites and breakdown products from
either microbial or chemical sources and the relevant sections in the
regulation and data requirements should be rewritten accordingly. In
addition, there is a need to increase the awareness among stakeholders,
including the regulatory experts, of the differences between these two
radically different types of substances.
Conclusion and recommendation (3)
MCAs and consequently their secondary metabolites are not
known to accumulate in the environment because they are de-
graded within complex microbial communities/degradative food
webs. Therefore, we suggest that not too much emphasis need to
be placed on data requirements on the secondary metabolite de-
gradation in the environment.
Metabolites and breakdown products from either microbial or
chemical source are two radically different substances. Lucid,
robust definitions are required which distinguish between these.
The relevant sections in the regulation and data requirements
should be rewritten to reflect this. There is also a need to increase
the awareness among stakeholders of the differences between
metabolites from microbials and those from chemicals.
4. Flaws in the current data requirements for metabolites
4.1. The term ‘relevant metabolite’ is ill defined
The definition in Article 3(32) of the Regulation 1107/2009 is: “A
metabolite is deemed relevant if there is a reason to assume that it has in-
trinsic properties comparable to the parent substance in terms of its biological
target activity, or that it poses a higher or comparable risk to organisms than
the parent substance or that it has certain toxicological properties that are
considered unacceptable. Such a metabolite is relevant for the overall ap-
proval decision or for the definition of risk mitigation measures”.
In this definition, the metabolite is compared with the ‘parent
substance’. The definition is therefore exclusively referring to the
toxicity of a chemical agent. Such a comparison is highly significant for
toxicity evaluation of chemical actives since intermediates (‘metabo-
lites’) in the degradation pathways of the compound may be equally or
even more toxic than the parent compound. However, this definition of
a ‘relevant metabolite’ of a chemical is not useful in the evaluation of
secondary metabolites of MCAs, since it ignores the biological and
ecological properties and roles of secondary metabolites produced by
micro-organisms.
EU regulation 283/2013 contains the most recent publication of the
data requirements for both the chemical and microbial active agents
(parts A and B, respectively). Those for the microbial active agents
though, were not changed since 2001. In part A for chemical substances
certain environmental studies are requested for “metabolites, breakdown
and reaction products” when “they account for more than 10% of the
amount of active substance added at any time during the studies” (see Data
requirement 7.1.2.1.2). Thus, degradation products accounting for
Fig. 4. Different possibilities of formation of ‘metabolites’ from chemicals, microorganisms (either MCAs or endophytes) and plants.
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more than 10% of the parent seem to be considered as ‘relevant’. It is
clear that the 10% of the active substance cut-off rule can only refer to
the breakdown products of chemical substances since metabolites of
micro-organisms cannot be expressed as a percentage of the micro-or-
ganisms. An attempt to define the relevant metabolite in part B for
micro-organisms (without using the 10% rule) is given in point 1.4.2:
“Relevant metabolites (i.e. if expected to be of concern to human health
and/or the environment)….”. Unfortunately, this definition fails to
clarify how much evidence is needed for something to be considered
‘expected’ and when is it a ‘concern’? The definition is liable to many
different interpretations and poses a major challenge to address by in-
dustry and risk assessors.
Conclusion and recommendation (4)
The term ‘relevant metabolite’ is defined for chemical pesti-
cides. Although used successfully in the evaluation of chemicals,
this term is not applicable to microbial metabolites. It ignores the
biological/ecological properties and roles of secondary metabo-
lites. Based on the argument above, we question whether the term
‘relevant metabolite’ should at all be used in the data require-
ments for MCAs.
The term ‘relevant metabolite’ seems firmly embedded in the
regulation texts. Once revision of the data requirements is in-
itiated, it would be timely to remove the term or to replace it with
one which is more lucid in its meaning.
4.2. Confusing requests for secondary metabolites in many data
requirements
Several requirements for micro-organisms raise questions on
secondary metabolites (Table 3). Often, the focus of the individual data
requirements is primarily on properties of the MCA, with references to
secondary metabolites almost being incidental. Only Data requirement
2.8 specifically requests information on the production of secondary
metabolites. Overall, this has resulted in the duplication of information
being requested. The terminology of the texts varies between individual
data requirements, resulting in confusion. The non-uniform use of the
term “metabolite” (Table 3, third column) is compounding the problem.
Data requirement 2.8 focuses on known toxins with unacceptable
effects explicitly stating that information should only be provided when
known toxins are formed by related strains of the same species
(Table 4). The rationale is that an MCA may theoretically produce
harmful toxins known to be produced by phylogenetically related spe-
cies. The other data requirements do not make reference to known
metabolites, but many focus on toxins. This explains why regulatory
experts request information on metabolites in general and not just the
known metabolites as requested in Data requirement 2.8 (Tables 3 and
4).
Conclusion and recommendation (5)
Only Data requirement 2.8 is specifically requesting ‘in-
formation on the production of metabolites (especially toxins)’ and on
‘known’ toxins. In several other data requirements, which focus on
the MCA properties, information on any toxic secondary meta-
bolite is requested in addition. In these data requirements dif-
ferent terminology is used which is liable to different inter-
pretations. The current confusion could be mitigated by rewriting
the data requirements, using well defined and unambiguous ter-
minology.
Table 3
Data requirements in Commission Regulation (EU) 283/2013 for micro-organisms requesting information on metabolites. In bold Data requirement 2.8 is specifically
addressing secondary metabolites.
Section/Data requirement Primary focus of data
requirements
Indication of the metabolite in the text of data requirements
Introduction (viii) Micro-organism Toxins/metabolites
1.4.2 Identity and content of impurities, additives, contaminating
micro-organisms
Micro-organism Relevant metabolites
2.2.2 Mode of action Micro-organism A toxin with a residual effect; metabolites (especially toxins)
2.4 Development stages/life cycle of the micro-organism Micro-organism Metabolites, including toxins that are of concern for human health and/
or the environment
2.5 Infectiveness, dispersal and colonization ability Micro-organism Relevant toxins
2.8 Information on the production of metabolites (especially
toxins)
Secondary metabolite Metabolites (especially toxins) with unacceptable effects on human
health and/or the environment
4.2 Methods to determine and quantify residues (viable or non-
viable)
Micro-organism Relevant metabolites (especially toxins)
6.1 Persistence and likelihood of multiplication in or on crops,
feeding stuffs or foodstuffs
Micro-organism Relevant secondary metabolites (especially toxins)
6.2.1 Non-viable residues Micro-organism Metabolites, especially toxins
7 Fate and behaviour in the environment, introduction Micro-organism Relevant metabolites
Table 4
Information to be provided under Data requirement 2.8.
If other strains belonging to the same microbial species as the strain subject to the application are known to produce metabolites (especially toxins) with unacceptable effects on human
health and/or the environment during or after application following information should be provided
1 The nature and structure of this substance
2 Its presence inside or outside the cell and its stability
3 Its mode of action (including external and internal factors of the micro-organism necessary to action)
4 Its effect on humans, animals or other non-target species
5 The conditions under which the micro-organism produces the metabolite(s) (especially toxin(s)) must be described
6 Any available information on the mechanism by which the microorganisms regulate the production of the(se) metabolite(s).
7 Any available information on the influence of the produced metabolites on the micro-organism's mode of action.
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5. Secondary metabolites under different regulations
Much attention is given to secondary metabolites of MCAs but the
EU regulatory system overlooks the fact that the same species occur
naturally as part of the soil or plant “microbiome”. The microbiome
consists of complex, dynamic populations of disparate epi- and en-
dophytic micro-organisms. They produce a plethora of known and un-
known bioactive metabolites, yet this has never been perceived as
posing any kind of risk as opposed to metabolites produced by MCAs.
Comparison with other types of organisms which also generate
secondary metabolites is of interest in this respect. For example, the
plant-based biopesticides, the “botanicals”, are useful plant protection
products that depend on an array of active metabolites. However, in the
current guidelines for botanicals, these metabolites are treated differ-
ently compared to MCA metabolites (EU, 2014; FAO/WHO, 2017;
OECD, 2017). It is notable that not once do these guidance documents,
in those parts treating the botanicals, mention the word “metabolite”.
Definitions relating to “metabolite” production have instead been re-
placed with the concept “component of concern”, defined as “any
component which has an inherent capacity to cause an adverse effect on
humans, animals or the environment and is present or is produced in a plant
protection product in sufficient concentration to present risk of such an ef-
fect.” This definition disregards the type of metabolic pathways that
leads to production of a compound. From a risk perspective, this seems
a sound approach, since the essential issue is the potential for adverse
(including toxic) effects. It is of subordinate importance if a compound
(of concern) is a primary metabolite, a secondary metabolite, a polymer
or something else.
Conclusion and recommendation (6)
Production of secondary metabolites is not specific to micro-
organisms, as plants and other groups of organisms collectively
produce a multitude of secondary metabolites. Clearly, micro-
organisms and their metabolites (primary or secondary) are in-
tegral parts of the natural biota to which humans are con-
tinuously exposed.
When put into this context, current risk assessment of sec-
ondary metabolites of MCAs appears to be disproportionate and
needs to be reconsidered.
6. Current and proposed risk assessment approach
6.1. Current secondary metabolite toxicity endpoint and exposure data
issues
A wide range of toxicity tests and endpoints are available for de-
termining toxicity of microbial metabolites to non-target organisms.
However, the designs and endpoints of most tests have been generated
for other purposes than pest control. Scientists designing these tests
include natural product chemists prospecting for new lead compounds
to develop into therapeutics, pathologists seeking to elucidate the role
of secondary metabolites in pathogenesis/antagonism and toxicologists
wishing to determine the potential impact of such compounds on hu-
mans. Since much of this data is available in the public domain, ap-
plicants can base their assessment on these findings, even though the
tests and/or endpoints may not be pertinent to MCAs.
Examples of potentially irrelevant endpoints are the in vitro inhibi-
tion of mammalian cancer cell growth by metabolites of Beauveria
bassiana (Mudgal et al., 2013), cytotoxicity observed in in vitro tests
with boar semen (Hackl et al., 2015) or increase in the incidence of
micronucleated erythrocytes at high dose only (EFSA, 2017). Such tests
indicate that certain (high) amounts of a secondary metabolite could be
cytotoxic in vitro, however, these results cannot be easily extrapolated
to intact animals and relevant environmental exposures. It can be
questioned whether such non-OECD, non-data requirement tests should
trigger animal testing.
6.2. Proposed risk assessment approach
Future data requirements and guidance on secondary metabolites
should differentiate better between toxigenic and beneficial micro-or-
ganisms and aim to categorise these according to the risks they pose.
This will require a good understanding of the evolution and ecological
role of these groups of micro-organisms. Such guidance will allow for
more informed risk assessments to be made and accelerate the whole
process. Progress in differentiating between these groups of micro-or-
ganisms is presented in a recent OECD review on microbial secondary
metabolites (OECD, 2018a).
The USA practices a hazard-based approach: an MCA is considered
to have little or no risk if tests and literature reviews show no indication
that it produces toxins in quantities that could be deleterious when the
MCA is deployed as a plant protection product (OECD, 2018b). The
product can then be admitted to the market.
Two EU funded projects, RAFBCA and REBECA (Strasser and
Pernfuss, 2005; Strasser et al., 2011, 2008) suggested inclusion of some
tests purely to provide that kind of reassurance that the secondary
metabolites pose little risk (e.g. (Garrido-Jurado et al., 2016; Skrobek
and Butt, 2005)). However, except for the AMES (genotox) and ecotox
(e.g. Daphna, Artemia) tests, the other tests proposed (e.g. tests against
animal cell lines) still have to be confirmed as acceptable by the reg-
ulatory authorities for risk assessment of MCAs. In selected tests the
potential toxin production by an MCA can be evaluated by using crude
extracts from culture filtrates that would contain the widest range of
metabolites the micro-organism could ever produce in vitro (RAFBCA
and REBECA recommendation). This approach has several highly
commendable attributes. It is largely indifferent to variations in culture
conditions and isolates and would take into account any additive or
synergistic interactions between different compounds. Furthermore, it
represents the ‘‘worst case scenario’’ since the metabolites are more
concentrated than they would be in natural systems. If tests have a clear
negative result crude extracts can be a useful tool. However, if there are
(geno)toxic effects seen with the crude extract the problem arises that
a) it is unknown which toxin is producing the effect, and b) it is very
difficult to translate the (high) doses in those lab tests to the actual in
situ field exposure. So in cases of effects, the crude extracts may un-
necessarily complicate the risk assessment.
Conclusion and recommendation (7)
There is a need for clear toxicity and exposure data require-
ments based on agreed tests and endpoints reflecting the actual
(in situ-field) risk. We conclude that a more hazard-based ap-
proach (practiced in other parts of the world) for evaluation of
potential production of toxins by an MCA, can be a good way
forward. The production of unknown, potentially toxic, sub-
stances does not need to be further considered, if a basic hazard
assessment is passed without any concerns.
The aim should be to do as few toxicology tests as possible. For
known toxins, the focus should be on the substance itself. For un-
knowns, and in perspective of updated data requirements, tests are not
recommended. A thorough literature search might be sufficient to
conclude that unknown toxins are not an issue. Based on the outcomes,
a revised strategy for tests/investigations can be established. The crude
extract approach, for example, could be suitable in situations where it is
considered motivated to “screen” for unknowns.
7. What is the way forward?
In this review we address several topics related to the EU data
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requirements of secondary metabolites and pinpoint specific issues that
cause difficulties in the risk assessment. The sources of the problems are
diverse and have a strong historical component. Current data require-
ments and evaluations of secondary metabolites from MCAs are based
on chemical principles and have a poor foundation in microbiological
science. We show in this paper that the current EU data requirements
relating to secondary metabolites are inconsistent and more compli-
cated than necessary to apply in risk assessment. Unfortunately, many
of the difficulties persist almost 20 years after their preparation.
Looking at the problems retrospectively gave us clues to their simpli-
fication, which is urgently needed.
In short, our primary recommendations are:
• New data requirements for microbial plant protection products must
be based on the biological and ecological properties and hazards of
micro-organisms.• Measuring secondary metabolites in situ is not useful, unless a
known toxin is produced.• There is clearly a need to redraft the data requirements for sec-
ondary metabolites of MCAs to make them more pertinent to micro-
organisms, using well-defined and unambiguous terminology. Lucid,
robust definitions are required which can distinguish between me-
tabolites and breakdown products from either microbial or chemical
sources. There is also a need to increase the awareness among reg-
ulatory experts, risk assessors and applicants of the differences be-
tween metabolites from microbial and synthetic origin.• The term and concept ‘relevant metabolite’, used successfully in the
evaluation of chemical pesticides, is not applicable to microbial
metabolites and causes much confusion. We propose that this term
should not be used in data requirements for MCAs.• We propose that revised data requirements for MCAs adopt a more
hazard-based approach for evaluation of the potential toxin pro-
duction of MCAs. Given that a basic hazard assessment is passed
without any concerns, the production of unknown, potentially toxic,
substances does not need to be further investigated.
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